This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Glycopyrrolate

Read time: 1 mins
Marketing start date: 23 Nov 2024
...
 

Summary of product characteristics


Effective Time

20221105

Version

2

Spl Product Data Elements

Glycopyrrolate Glycopyrrolate GLYCOPYRROLATE GLYCOPYRRONIUM BENZYL ALCOHOL HYDROCHLORIC ACID SODIUM HYDROXIDE WATER Glycopyrrolate Glycopyrrolate GLYCOPYRROLATE GLYCOPYRRONIUM BENZYL ALCOHOL HYDROCHLORIC ACID SODIUM HYDROXIDE WATER Glycopyrrolate Glycopyrrolate GLYCOPYRROLATE GLYCOPYRRONIUM BENZYL ALCOHOL HYDROCHLORIC ACID SODIUM HYDROXIDE WATER Glycopyrrolate Glycopyrrolate GLYCOPYRROLATE GLYCOPYRRONIUM BENZYL ALCOHOL HYDROCHLORIC ACID SODIUM HYDROXIDE WATER

Application Number

ANDA214213

Brand Name

Glycopyrrolate

Generic Name

Glycopyrrolate

Product Ndc

70771-1619

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAMUSCULAR,INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1616-1 Glycopyrrolate Injection, USP 0.2 mg/mL NOT FOR USE IN NEWBORNS CONTAINS BENZYL ALCOHOL FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION 1 mL Single-Dose Vial Rx only NDC 70771-1616-7 Glycopyrrolate Injection, USP 0.2 mg/mL NOT FOR USE IN NEWBORNS CONTAINS BENZYL ALCOHOL FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION 25 x 1 mL Single-Dose Vials Rx only NDC 70771-1617-1 Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) NOT FOR USE IN NEWBORNS CONTAINS BENZYL ALCOHOL FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION 2 mL Single-Dose Vial Rx only NDC 70771-1617-7 Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) NOT FOR USE IN NEWBORNS CONTAINS BENZYL ALCOHOL FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION 25 x 2 mL Single-Dose Vials Rx only NDC 70771-1618-1 Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) NOT FOR USE IN NEWBORNS CONTAINS BENZYL ALCOHOL FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION 5 mL Multiple-Dose Vial Rx only NDC 70771-1618-7 Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) NOT FOR USE IN NEWBORNS CONTAINS BENZYL ALCOHOL FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION 25 x 5 mL Multiple-Dose Vials Rx only NDC 70771-1619-1 Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) NOT FOR USE IN NEWBORNS CONTAINS BENZYL ALCOHOL FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION 20 mL Multiple-Dose Vial Rx only NDC 70771-1619-6 Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) NOT FOR USE IN NEWBORNS CONTAINS BENZYL ALCOHOL FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION 10 x 20 mL Multiple-Dose Vials Rx only 1 mL vial carton of 25 of 1 mL vial 2 mL vial carton of 2 mL 25 vials 5 mL vial carton of 25 of 5 mL vial 20 mL vial carton of 10 - 20 mL vials

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.